Skip to main content
David Maloney, MD, Oncology, Seattle, WA, UW Medicine/University of Washington Medical Center

DavidGeorgeMaloneyMD

Oncology Seattle, WA

Hematologic Oncology

Professor, Medicine, University of Washington School of Medicine

Dr. Maloney is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Maloney's full profile

Already have an account?

Summary

  • Dr. David Maloney is an oncologist in Seattle, WA and is affiliated with multiple hospitals in the area, including Seattle Cancer Care Alliance, Seattle Children's Hospital, and University of Washington Medical Center. He received his medical degree from Stanford University School of Medicine and has been in practice 32 years. He specializes in hematologic oncology and is experienced in hematologic oncology.

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1988 - 1994
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1985 - 1988
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 1985

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 1994 - 2024
  • CA State Medical License
    CA State Medical License 1988 - Present
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2008-2014
  • America's Top Doctors for Cancer Castle Connolly, 2007-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Long Term Follow-up of Tandem Autologous-Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma  
    Parameswaran Hari, Brenda M Sandmaier, Pamela S Becker, Leona Holmberg, Damian J Green, Peter A McSweeney, David G Maloney, Thomas R Chauncey, Haematologica
  • Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity After Adoptive Immunotherapy with CD19 CAR-T Cells  
    Mark Wurfel, David G Maloney, Kathleen R Fink, W Conrad Liles, Cameron J Turtle, Cecilia Yeung, Clinical Cancer Research

Abstracts/Posters

  • Response to Bcma CAR-T Cells Correlates with Pretreatment Target Antigen Density and Is Improved By Small Molecule Inhibition of Gamma Secretase
    David G. Maloney, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Factors Associated with Response, CAR-T Cell In Vivo Expansion, and Progression-Free Survival after Repeat Infusions of CD19 CAR-T CellsClinically Relevant Abstract
    David G. Maloney, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Outpatient Treatment with Lisocabtagene Maraleucel (liso-cel) in Three Ongoing Clinical Studies in Relapsed/Refractory (R/R) B Cell Non-Hodgkin Lymphoma (NHL), Includi...
    David G. Maloney, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Hit the Ground Running: What You Need to Know About CAR T-Cell Therapy 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B-Cell Lymphoma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Immunotherapy with T-Cells Engineered with a Chimeric Antigen Receptor Bearing a Human CD19-Binding Single Chain Variable Fragment for Relapsed or Refractory Acute Lym... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • Expert Highlights CAR T-cell Breakthroughs
    Expert Highlights CAR T-cell BreakthroughsNovember 1st, 2017
  • Fred Hutch Unveils First-of-Its-Kind Immunotherapy Clinic, Named After Bezos Family
    Fred Hutch Unveils First-of-Its-Kind Immunotherapy Clinic, Named After Bezos FamilyNovember 1st, 2016
  • A Medical Breakthrough That Hacks Genes to Fight Cancer Just Got Approved, and It's the Beginning of 'A Big New Field of Medicine'
    A Medical Breakthrough That Hacks Genes to Fight Cancer Just Got Approved, and It's the Beginning of 'A Big New Field of Medicine'September 1st, 2017
  • Join now to see all

Grant Support

  • Allogeneic HCT For Hematologic Malignancies: Pharmacologic ManipulationsNational Cancer Institute2009–2012
  • Mixed Chimerism In The Treatment Of B-Cell MalignanciesNational Cancer Institute2004–2008
  • Anti-Cd20 Antibody Therapy Of Nhl-- Mechanism Of ActionNational Cancer Institute2000–2002
  • Myeloma Idiotype VaccinesNational Cancer Institute1997

Hospital Affiliations